1. Home
  2. NRIX vs YELP Comparison

NRIX vs YELP Comparison

Compare NRIX & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$17.50

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$27.94

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
YELP
Founded
2009
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
NRIX
YELP
Price
$17.50
$27.94
Analyst Decision
Strong Buy
Hold
Analyst Count
12
6
Target Price
$30.50
$29.17
AVG Volume (30 Days)
1.2M
923.4K
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.15
EPS
N/A
2.24
Revenue
$76,987,000.00
$1,464,955,000.00
Revenue This Year
N/A
$2.19
Revenue Next Year
$40.12
$2.34
P/E Ratio
N/A
$12.25
Revenue Growth
99.31
3.75
52 Week Low
$8.20
$19.60
52 Week High
$22.50
$40.25

Technical Indicators

Market Signals
Indicator
NRIX
YELP
Relative Strength Index (RSI) 64.82 75.98
Support Level $16.81 $27.29
Resistance Level $19.98 $31.42
Average True Range (ATR) 0.92 0.68
MACD 0.23 0.26
Stochastic Oscillator 96.64 94.44

Price Performance

Historical Comparison
NRIX
YELP

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

Share on Social Networks: